In this study, we developed pH-responsiveporphyrin-peptide nanosheets with tumor-targeting capabilities (PRGD)that were loaded with the IDO inhibitor NLG919 for a dual applicationinvolving PDT and immunotherapy (PRGD/NLG919). This evidence concerns the gene IDO1 and neoplasm.